Press "Enter" to skip to content

Cipla acquires brand, trademark rights for anti-diabetic drug Vysov in India

Cipla has been co-marketing Vildagliptin in agreement with Novartis under brand names Vysov and Vysov M (Vildagliptin plus Metformin), the company said in a regulatory filing.

Original source:

Also Read:   Dr Reddy's launches anti-coagulant drug in US market